REQUEST A DEMO
Total
USD $0.00
Search more companies

WAGNER-PHARMA Kft. (Hungary)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: WAGNER-PHARMA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

WAGNER-PHARMA Kft. is based in Hungary, with the head office in Paradsasvar. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was established on July 27, 1993. WAGNER-PHARMA Kft. currently employs 49 (2024) people. In its most recent financial highlights, the company reported a net sales revenue drop of 2.32% in 2024. Its’ total assets recorded a negative growth of 4.98%. WAGNER-PHARMA Kft.’s net profit margin decreased by 14.28% in 2024.

Headquarters
Kossuth Lajos utca 44.
Paradsasvar; Heves; Postal Code: 3242

Contact Details: Purchase the WAGNER-PHARMA Kft. report to view the information.

Website: http://www.wagner.hu

Basic Information
Total Employees:
Purchase the WAGNER-PHARMA Kft. report to view the information.
Registered Capital:
Purchase the WAGNER-PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the WAGNER-PHARMA Kft. report to view the information.
Incorporation Date:
July 27, 1993
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Praxipharm Kereskedelmi Kft.
Wagner-Heli Kft.
Company Performance
Financial values in the chart are available after WAGNER-PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-2.32%
Total operating revenue
-1.23%
Operating profit (EBIT)
-41.24%
EBITDA
-36.65%
Net Profit (Loss) for the Period
-36.29%
Total Assets
-4.98%
Total Equity
-5.78%
Operating Profit Margin (ROS)
-17.57%
Net Profit Margin
-14.28%
Return on Equity (ROE)
-8.13%
Quick Ratio
0%
Cash Ratio
0.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?